ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Alloantibodies"

  • 2019 American Transplant Congress

    Use Of Perirenal Adipose Tissue As A Source Of Donor Cells Allowing Evaluation Of Endothelial Inflammation And Quality Of Expanded Criteria Kidneys

    R. Boissier1, L. Lyonnet2, P. Francois3, M. Meunier4, B. Gondran-Tellier5, T. Legris6, J. Magalon5, C. Picard7, F. Dignat George5, E. Lechevallier8, G. Karsenty8, F. Sabatier9, P. Paul1

    1INSERM 1263, Centre de recherche en cardiovasculaire et nutrition, INSERM, Aix Marseille Univ, Assistance Publique Hopitaux Marseille, Marseille, France, 2Vascular Biology and Hematology department, Assistance publique Hopitaux Marseille (AP-HM), Marseille, France, 3INSERM 1263, Centre de recherche en cardiovasculaire et nutrition, INSERM, Aix Marseille Univ., Marseille, France, 4Nephrology Dialysis and Renal Transplantation Center, AP-HM, Marseille, France, 5INSERM 1263, C2VN, INSERM, Aix Marseille Univ., Marseille, France, 6Nephrology Dialysis and Renal Transplantation Center, AP-HM, Marseille, France, 7Etablissement Français du Sang, Alpes Méditerranée, Marseille, France, 8Urology and Transplantation Unit , AP-HM, Marseille, France, 9INSERM 1263, Centre de recherche en cardiovasculaire et nutrition, INSERM, Aix Marseille Univ, Marseille, France

    *Purpose: Use of expanded-criteria donor (ECD) kidneys is a perspective to overcome organ shortage. Age and donor-related co-morbidy factors are known to affect graft function…
  • 2019 American Transplant Congress

    Cluster Analysis of Microvascular Inflammation in Indication Biopsies Unveils Distinct Pathological and Immunological Phenotypes with Prognostic Implications

    J. Malheiro1, A. Silva1, S. Santos1, S. Tafulo2, L. Martins1, L. Dias1, A. Castro-Henriques1

    1Centro Hospitalar do Porto, Porto, Portugal, 2IPST_Porto, Porto, Portugal

    *Purpose: We aimed to define distinct pathological and immunological clusters of 80 cases of MVI diagnosed in indication biopsies and evaluate their prognostic implications.*Methods: The…
  • 2019 American Transplant Congress

    Platelets Augment Granzyme K Production By Macrophages In Antibody-mediated Rejection

    J. Dhar, K. Keslar, R. Fan, N. Dvorina, W. Baldwin

    Cleveland Clinic Main Campus, Lerner Research Institute, Cleveland, OH

    *Purpose: When antibodies bind to MHC antigens on endothelial cells a cascade of responses is initiated including exocytosis of adhesion molecules followed by attachment and…
  • 2019 American Transplant Congress

    Donor-Derived Cell-Free DNA is Associated Specifically with Antibody Mediated Injury in Patients with Renal Allograft Dysfunction

    B. Obrisca1, C. Blosser2, I. De Castro2, C. Johnson2, B. Sorohan1, L. Sibulesky2, R. Bakthavatsalam2, G. Ismail1, N. Leca2

    1Fundeni Clinical Institute, Bucharest, Romania, 2University of Washington, Seattle, WA

    *Purpose: Donor-derived cell-free DNA (dd-cfDNA) has been proposed as a noninvasive biomarker to differentiate rejection from other types of injury in renal allografts.*Methods: We analyzed…
  • 2019 American Transplant Congress

    Immediate Post Reperfusion In Vivo Transcriptional Responses of Individual Human Renal Allograft Cell Populations to Circulating Anti-Angiotensin II Type I Receptor Antibody

    C. M. Castro -Rojas1, N. Salomonis2, K. Chetal2, R. R. Alloway3, E. Woodle3, D. A. Hildeman1

    1Immunobiology, Cincinnati Children's Hospital, Cincinnati, OH, 2Biomedical Informatics, Cincinnati Children's Hospital, Cincinnati, OH, 3Transplantation, University of Cincinnati College of Medicine, Cincinnati, OH

    *Purpose: Pre-existing anti-angiotensin II type I receptor (AT1R) antibodies can be a significant driver of allograft rejection. Indeed, prior work has shown that AT1R antibodies…
  • 2019 American Transplant Congress

    Costimulation Blockade Modulates Humoral Responses in Highly Sensitized Transplant Recipients

    J. Kwun, B. Ezekian, P. Schroder, M. Manook, J. Yoon, M. Mulvihill, K. Freischlag, J. Yi, S. Knechtle

    Surgery, Duke Transplant Center, Durham, NC

    *Purpose: Broad human leukocyte antigen sensitization is a significant barrier to successful solid organ transplantation. Sensitized patients have poor access to donor organs, high wait…
  • 2019 American Transplant Congress

    Increasing Net Immunosuppression after BK Viremia

    L. Cotiguala, A. Masood, J. Park, A. Naik

    University of Michigan, Ann Arbor, MI

    *Purpose: BK viremia is associated with inferior kidney allograft outcomes. Typical treatment involves reduction in immunosuppression. However reduction in immunosuppression is also likely to lead…
  • 2019 American Transplant Congress

    Unifying Interpretation of Molecular HLA Typing Data between the Solid Organ Allocation Match Run and Virtual Crossmatch

    N. Kaur1, E. Kransdorf2, M. Pando3, L. Gragert1

    1Tulane University School of Medicine, New Orleans, LA, 2Cedars-Sinai Heart Institute, Los Angeles, CA, 3Baylor Scott & White, Temple, TX

    *Purpose: Virtual crossmatch compares a transplant candidate’s HLA antibody assay results to the HLA typing of the donor before an organ offer is accepted. While…
  • 2019 American Transplant Congress

    Is HLA Donor-Specific Antibody (DSA)-C3d+ Assay a Potential Predictor of Subclinical Antibody Mediated Damage in the Renal Graft?

    A. G. Contreras1, M. I. Solis-G1, C. Ramirez-Espinoza1, J. Hernandez-Rosales2, M. Vilatoba-Chapa1, R. Cruz-Martínez1, J. Granados1, L. E. Morales-Buenrostro3, J. Alberú1, J. M. Arreola-Guerra4

    1Transplantation, Instituto Nacional de Ciencias Medicas y Nutricion SZ, Mexico City, Mexico, 2Department of Histocompatibility, Laboratorio Clinico del Campestre, Mexico City, Mexico, 3Nephrology-Mineral Metabolism, Instituto Nacional de Ciencias Medicas y Nutricion SZ, Mexico City, Mexico, 4Internal Medicine, Centenario Hospital Miguel Hidalgo, Mexico City, Mexico

    *Purpose: The Aim of the study was to explore the predictive value of the C3d assay for tissue damage in kidney transplant recipients (KTR) in…
  • 2019 American Transplant Congress

    Long-Term Outcomes of Eculizumab-Treated Positive Crossmatch Recipients: Allograft Survival, Histologic Findings, and Natural History of the Donor-Specific Antibodies

    C. Schinstock, A. Bentall, S. Byron, L. Cornell, M. Everly, M. Gandhi, M. Stegall

    Mayo Clinic, Rochester, MN

    *Purpose: We aimed to determine long-term outcomes for eculizumab-treated, positive crossmatch (+XM) kidney transplant recipients as compared with +XM and age-matched negative crossmatch (−XM) control…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 40
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences